Updated Review on Clinically-Relevant Properties of Delafloxacin

被引:6
|
作者
Turban, Adrien [1 ]
Guerin, Francois [1 ,2 ]
Dinh, Aurelien [3 ]
Cattoir, Vincent [1 ,2 ]
机构
[1] Univ Hosp Rennes, Dept Bacteriol, 2 Rue Henri Le Guilloux, F-35000 Rennes, France
[2] Univ Rennes, Inserm, UMR S 1230 BRM, 2 Ave Pr Leon Bernard, F-35000 Rennes, France
[3] Versailles St Quentin Univ, Univ Hosp Raymond Poincare, AP HP, Infect Dis Dept,Paris Saclay, F-92380 Garches, France
来源
ANTIBIOTICS-BASEL | 2023年 / 12卷 / 08期
关键词
fluoroquinolones; levofloxacin; moxifloxacin; resistance; topoisomerases; ABSSSI; CAP; ACUTE BACTERIAL SKIN; IN-VITRO ACTIVITY; STAPHYLOCOCCUS-AUREUS; TOPOISOMERASE-IV; STREPTOCOCCUS-PNEUMONIAE; STRUCTURE INFECTIONS; DNA GYRASE; QUINOLONE ACTION; DOUBLE-BLIND; PHASE-III;
D O I
10.3390/antibiotics12081241
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The extensive use of fluoroquinolones has been consequently accompanied by the emergence of bacterial resistance, which triggers the necessity to discover new compounds. Delafloxacin is a brand-new anionic non-zwitterionic fluoroquinolone with some structural particularities that give it attractive proprieties: high activity under acidic conditions, greater in vitro activity against Gram-positive bacteria-even those showing resistance to currently-used fluoroquinolones-and nearly equivalent affinity for both type-II topoisomerases (i.e., DNA gyrase and topoisomerase IV). During phases II and III clinical trials, delafloxacin showed non-inferiority compared to standard-of-care therapy in the treatment of acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia, which resulted in its approval in 2017 by the Food and Drug Administration for indications. Thanks to its overall good tolerance, its broad-spectrum in vitro activity, and its ease of use, it could represent a promising molecule for the treatment of bacterial infections.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Clinically-relevant cardiopulmonary interactions for the pediatric intensivist
    Sasser, William C.
    Sims, Andrea N.
    Loberger, Jeremy M.
    Tofil, Nancy M.
    Prabhakaran, Priya
    MINERVA PEDIATRICA, 2019, 71 (01) : 76 - 81
  • [2] Testing knowledge of clinically-relevant surface anatomy
    Hankin, Mark
    Baptista, Carlos A. C.
    Lane, Richard D.
    Morse, Dennis E.
    Bennett-Clarke, Carol A.
    FASEB JOURNAL, 2010, 24
  • [3] Psychometric properties of a brief, clinically-relevant measure of pain in patients with hepatocellular carcinoma
    Butt, Zeeshan
    Lai, Jin-Shei
    Beaumont, Jennifer
    Kaiser, Karen
    Mallick, Rajiv
    Cella, David
    Steel, Jennifer L.
    QUALITY OF LIFE RESEARCH, 2013, 22
  • [4] Clinically-relevant and predictive cancer models for nanomedicine evaluation
    Satchi-Fainaro, Ronit
    Florindo, Helena F.
    Vicent, Maria J.
    ADVANCED DRUG DELIVERY REVIEWS, 2022, 183
  • [5] Dentin deformation after scratching with clinically-relevant forces
    Camps, J
    Salomon, JP
    Van Meerbeek, B
    Tay, F
    Pashley, D
    ARCHIVES OF ORAL BIOLOGY, 2003, 48 (07) : 527 - 534
  • [6] Detecting clinically-relevant changes in progressive multiple sclerosis
    Bosma, L. V. A. E.
    Sonder, J. M.
    Kragt, J. J.
    Polman, C. H.
    Uitdehaag, B. M. J.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (02) : 171 - 179
  • [7] Comparison of macro-, micro- and nanomechanical properties of clinically-relevant UHMWPE formulations
    Slouf, Miroslav
    Arevalo, Sofia
    Vlkova, Helena
    Gajdosova, Veronika
    Kralik, Vlastimil
    Pruitt, Lisa
    JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2021, 120 (120)
  • [8] Considerations for clinically-relevant nanomedicine therapies for chronic diseases
    Owen, Andrew
    Rannard, Steve
    NANOMEDICINE, 2015, 10 (20) : 3103 - 3107
  • [9] GROWTH OF NEONATAL BACTERIAL PATHOGENS IN CLINICALLY-RELEVANT SURFACTANTS
    SHERMAN, MP
    BAILYN, E
    CAMPBELL, L
    PEDIATRIC RESEARCH, 1989, 25 (04) : A231 - A231
  • [10] Clinically-relevant anticancer-antidepressant drug interactions
    Chan, Alexandre
    De Ng, Terence Rong
    Yap, Kevin Yi-Lwern
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (02) : 173 - 199